MedTrace Logo

Treatment Outcome Using Vivaer Stylus to Treat Nasal Airway Obstruction

NCT03156270 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2021-06-16

Study results available
· View outcomes & findings →

Summary

This study evaluates subjective and objective measures of treatment outcome after using the Aerin Medical Vivaer™ Stylus to treat nasal obstruction

Conditions

  • Nasal Obstruction

Interventions

DEVICE

Vivaer Stylus

Stylus used to deliver low-power, temperature-controlled, radiofrequency energy to the tissues of the internal nasal valve area

Sponsors & Collaborators

  • Ohio State University

    collaborator OTHER

  • Aerin Medical

    lead INDUSTRY

Principal Investigators

  • Brad Otto, MD · The Ohio State Eye and Ear Institute

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-19
Primary Completion
2019-07-12
Completion
2019-08-06
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03156270 on ClinicalTrials.gov